Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and Efficacy
Clinical trial NCT02749331 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02749331
- Sponsor
- Uppsala University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2025-08-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.